Pre-earnings options volume in Janux Therapeutics is normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move near 5.7%, or $2.28, after results are released. Median move over the past eight quarters is 6.8%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JANX: